PortalPublikationenValue of repeat resection for survival in pulmonary metastas...

Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.

Standard

Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. / Deutsch, Lena; Elson, F; Quaas, Alexander; Gawad, Karim A.; Izbicki, Jakob R.

in: ANTICANCER RES, Jahrgang 27, Nr. 4, 4, 2007, S. 2897-2902.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Deutsch, L, Elson, F, Quaas, A, Gawad, KA & Izbicki, JR 2007, 'Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.', ANTICANCER RES, Jg. 27, Nr. 4, 4, S. 2897-2902. <http://www.ncbi.nlm.nih.gov/pubmed/17695468?dopt=Citation>

APA

Deutsch, L., Elson, F., Quaas, A., Gawad, K. A., & Izbicki, J. R. (2007). Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. ANTICANCER RES, 27(4), 2897-2902. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17695468?dopt=Citation

Vancouver

Deutsch L, Elson F, Quaas A, Gawad KA, Izbicki JR. Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. ANTICANCER RES. 2007;27(4):2897-2902. 4.

Bibtex

@article{c6ccd5f876f647fd970fc7b7839ac99b,
title = "Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.",
abstract = "BACKGROUND: Pulmonary metastasectomy in soft tissue sarcoma (STS) can lead to long-term survival. The aim of our study was to report on prognostic factors and the value of repeat resection in recurrent disease. PATIENTS AND METHODS: Seventy-eight pulmonary metastasectomies were performed on 42 STS patients from 1990 to 2005. Overall survival time and 3-year survival rate were evaluated. Subgroup analysis was performed on age, primary tumor stage, histological type and grade, occurrence and recurrence pattern, systemic treatment and number of resections. RESULTS: The 3-year actuarial survival rate was 31%. Primary tumor grade and repeat resections were shown to be independent prognostic factors for survival. CONCLUSION: Patients with repeat resections due to recurrent metastasis show a significantly better prognosis than those with only one resection. Thus, lacking randomised controlled data of the natural course of patients with unresected lung metastases to compare these results, metastasectomy in STS patients is also recommended in recurrent disease.",
author = "Lena Deutsch and F Elson and Alexander Quaas and Gawad, {Karim A.} and Izbicki, {Jakob R.}",
year = "2007",
language = "Deutsch",
volume = "27",
pages = "2897--2902",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

RIS

TY - JOUR

T1 - Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.

AU - Deutsch, Lena

AU - Elson, F

AU - Quaas, Alexander

AU - Gawad, Karim A.

AU - Izbicki, Jakob R.

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Pulmonary metastasectomy in soft tissue sarcoma (STS) can lead to long-term survival. The aim of our study was to report on prognostic factors and the value of repeat resection in recurrent disease. PATIENTS AND METHODS: Seventy-eight pulmonary metastasectomies were performed on 42 STS patients from 1990 to 2005. Overall survival time and 3-year survival rate were evaluated. Subgroup analysis was performed on age, primary tumor stage, histological type and grade, occurrence and recurrence pattern, systemic treatment and number of resections. RESULTS: The 3-year actuarial survival rate was 31%. Primary tumor grade and repeat resections were shown to be independent prognostic factors for survival. CONCLUSION: Patients with repeat resections due to recurrent metastasis show a significantly better prognosis than those with only one resection. Thus, lacking randomised controlled data of the natural course of patients with unresected lung metastases to compare these results, metastasectomy in STS patients is also recommended in recurrent disease.

AB - BACKGROUND: Pulmonary metastasectomy in soft tissue sarcoma (STS) can lead to long-term survival. The aim of our study was to report on prognostic factors and the value of repeat resection in recurrent disease. PATIENTS AND METHODS: Seventy-eight pulmonary metastasectomies were performed on 42 STS patients from 1990 to 2005. Overall survival time and 3-year survival rate were evaluated. Subgroup analysis was performed on age, primary tumor stage, histological type and grade, occurrence and recurrence pattern, systemic treatment and number of resections. RESULTS: The 3-year actuarial survival rate was 31%. Primary tumor grade and repeat resections were shown to be independent prognostic factors for survival. CONCLUSION: Patients with repeat resections due to recurrent metastasis show a significantly better prognosis than those with only one resection. Thus, lacking randomised controlled data of the natural course of patients with unresected lung metastases to compare these results, metastasectomy in STS patients is also recommended in recurrent disease.

M3 - SCORING: Zeitschriftenaufsatz

VL - 27

SP - 2897

EP - 2902

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 4

M1 - 4

ER -